Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer

Cited by (289)

Items 101–200 of 289

1. KCNJ2/HIF1α positive-feedback loop promotes the metastasis of osteosarcoma
   M. Shen, Run-Sang Pan, Shan Lei, Lun Zhang, Changhua Zhou, Zhirui Zeng, Ying-Jie Nie, X. Tian · 2023 · Cell Communication and Signaling
2. Cancer stem cells in hepatocellular carcinoma: therapy resistance and emerging treatments
   Dipesh Kumar Yadav, Rajesh Kumar Yadav, Alina Singh, Yi‐Fang Huang, Dandan Bao, Zhangwei Yang, Hanzhang Huang, Yin Jiang, Pengwei Wang, Sisi Lin et al. · 2025 · Frontiers in Immunology
3. NAT10-mediated lipid metabolic reprogramming drives EGFR-TKI resistance in non-small cell lung cancer via ac4C-dependent mRNA stabilization
   Shuai Fang, Yuchao Zhu, Wei Chen, Wei-Min Mao, Yuan Fang, Zi-Yuan Chen, Zhiqi Hong, Xiao-Dong Zhao, Wenmin Su, Yuning Pan et al. · 2025 · Experimental Hematology & Oncology
4. Microalgae-based biodegradable embolic agent for the treatment of hepatocellular carcinoma through transarterial embolization
   Kaiyue Wang, Danni Zhong, Lingxiao Yang, Cheng Zeng, Qitao Hu, Min Zhou, Zhe Tang · 2025 · Journal of Nanobiotechnology
5. Radioresistance in Hepatocellular Carcinoma: Biological Bases and Therapeutic Implications
   Jian-hui Wu, Xiao-Fang Zhao, Bowen Ren, Xue-Zhang Duan, Jing Sun · 2025 · International Journal of Molecular Sciences
6. Pharmacological induction of the hypoxia response pathway in Huh7 hepatoma cells limits proliferation but increases resilience under metabolic stress
   Clémence Jacquemin, Walid El Orch, Olivier Diaz, Alexandre Lalande, Anne Aublin‐Gex, Florentine Jacolin, Johan Toesca, Mustapha Si‐Tahar, Cyrille Mathieu, Vincent Lotteau et al. · 2024 · Cellular and Molecular Life Sciences
7. A hypoxia-derived gene signature to suggest cisplatin-based therapeutic responses in patients with cervical cancer
   Jin Fang, Ying Wang, Chen Li, Weixiao Liu, Wannan Wang, Xue-Wei Wu, Yang Wang, Shuixin Zhang, Jing Zhang · 2024 · Computational and Structural Biotechnology Journal
8. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma
   Nicola Mosca, Aniello Russo, N. Potenza · 2023 · International Journal of Molecular Sciences
9. Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
   Zhonghao Jiang, C. Dai · 2023 · Journal of Hepatocellular Carcinoma
10. Identification of Prognostic and Predictive Biomarkers and Druggable Targets among 205 Antioxidant Genes in 21 Different Tumor Types via Data-Mining
    N. Ozenver, T. Efferth · 2023 · Pharmaceutics
11. Recent advances in chemodynamic nanotherapeutics to overcome multidrug resistance in cancers.
    Wenjia Xu, Min Wang, Xinyu Liu, Yucui Ding, Jianlong Fu, Peng Zhang · 2025 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
12. Development of hepatocellular carcinoma organoid model recapitulating HIF-1A metabolic signature
    Mennatallah A. Khedr, Zainab Mohamed, Azza M. El-derby, M. Soliman, Amira Abdel Fattah Edris, E. Badr, N. El-Badri · 2024 · Clinical and Experimental Medicine (Testo stampato)
13. Sensitizing sorafenib to hepatocellular carcinoma with dual-targeted and pH-responsive nanodrugs via overcoming the hypoxia tumor microenvironment
    Zhe Li, Jin-Shuai Lan, Ya Wu, Lixia Chen, Donghao Gu, Li-Yan Sun, Siqi Yang, Yi Shen, Tong Zhang, Yue Ding · 2024 · Chemical Engineering Journal
14. Sanguinarine Induces Necroptosis of HCC by Targeting PKM2 Mediated Energy Metabolism
    Rui Kong, Nan Wang, Chunli Zhou, Yuqing Zhou, Xiaoyan Guo, Dongyan Wang, Yi-Hai Shi, R. Wan, Y. Zheng, Jie Lu · 2024 · Cancers
15. TRIM33 enhances the ubiquitination of TFRC to enhance the susceptibility of liver cancer cells to ferroptosis
    Wenjing Ji, Weibin Zhang, Xin Zhang, Yue Ke · 2024 · Cellular Signalling
16. Adamantaniline Derivatives Target ATP5B to Inhibit Translation of Hypoxia Inducible Factor‐1α
    Huiti Li, Yali Liu, Zian Xue, Li Zhang, Xiaoxue Ruan, Jintong Yang, Zhongjiao Fan, Hongfang Zhao, Yu Cao, Guoqiang Chen et al. · 2023 · Advanced Science
17. An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma
    Wanyuan Ruan, Lun Zhang, Shan Lei, Zhirui Zeng, Yushi Yang, Wen-Peng Cao, Qiuyao Hao, Min Lu, X. Tian, P. Peng · 2023 · Journal of Cellular and Molecular Medicine
18. A novel hypoxia-driven gene signature that can predict the prognosis and drug resistance of gliomas
    Peng Ren, Jingya Wang, Zhirui Zeng, Nan Li, Hong-Lei Chen, Xin-Xin Peng, U. Bhawal, Wenbing Guo · 2022 · Frontiers in Genetics
19. Hypoxia responsive fucoidan-based micelles for oxidative stress-augmented chemotherapy
    Li Li, Bingjie Wang, Qi Zhang, Panpan Song, Tian-Ze Jiang, Xia Zhao · 2022 · European Polymer Journal
20. Intratumoral Pi deprivation benefits chemoembolization therapy via increased accumulation of intracellular doxorubicin
    Yang-Feng Lv, Zhixuan Deng, Qiu-chen Bi, Jianyuan Tang, Hong Chen, Chuan-sheng Xie, Qing-rong Liang, Yu-hua Xu, Rong-Guang Luo, Qun Tang · 2022 · Drug Delivery
21. Mechanisms of Immune Checkpoint Inhibitor Resistance in Hepatocellular Carcinoma and Strategies for Reversal
    Xin-Ye Dai, Xiao-Juan Yang, Hong Mei Wu, Yinghao Lv, Tian Lan · 2025 · Cancers
22. Research progress and therapeutic strategies in hepatocellular carcinoma metabolic reprogramming
    Haibo Wang, Yu Lun, Dongdong Xu, Han Jiang, Yumeng Yan, Xing Hai Yang · 2025 · Journal of Advanced Research
23. Elevated expression of HIGD1A drives hepatocellular carcinoma progression by regulating polyamine metabolism through c-Myc–ODC1 nexus
    Haixing Zhang, Xiaoran Li, Ziying Liu, Zimo Lin, Kuiyuan Huang, Yiran Wang, Yu Chen, Leyi Liao, Leyuan Wu, Zhanglian Xie et al. · 2024 · Cancer & Metabolism
24. High USP32 expression contributes to cancer progression and is correlated with immune infiltrates in hepatocellular carcinoma
    Mengxi Xiu, Wen-Fang Bao, Jia-Lin Wang, Jing-De Chen, Yan-Dong Li, Yanan Hai · 2023 · BMC Cancer
25. Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B
    Ping Yan, Yun-Hai Luo, Zuo-Tian Huang, Tong Mou, Hang Yang, Dadi Peng, Zhong-Jun Wu · 2023 · BMC Gastroenterology
26. Hypoxia-induced circSTT3A enhances serine synthesis and promotes H3K4me3 modification to facilitate breast cancer stem cell formation.
    Ming Xu, Xiaoqi Liu, Xinyue Zhou, Yi-Lu Qin, Liping Yang, S. Wen, Yuxiang Qiu, Shangchun Chen, Rui Tang, Yue-Tong Guo et al. · 2023 · Pharmacological Research
27. A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genes
    Qingmiao Shi, Chen Xue, Yifan Zeng, Xinyu Gu, Jinzhi Wang, Lanjuan Li · 2023 · Scientific Reports
28. Mitochondrial HIGD1A inhibits hepatitis B virus transcription and replication through the cellular PNKD‐NF‐κB‐NR2F1 nexus
    Zhanglian Xie, Sheng Shen, Kuiyuan Huang, Wei-Bin Wang, Zi-Ying Liu, Haixing Zhang, Meng-Ji Lu, Jian Sun, Jin-Lin Hou, Hong-Yan Liu et al. · 2023 · Journal of Medical Virology
29. PEG-conjugated bovine haemoglobin enhances efficiency of chemotherapeutic agent doxorubicin with alleviating DOX-induced splenocardiac toxicity in the breast cancer
    Bingting Li, Jun Zhang, Ning Ma, Weidan Li, Guoxing You, Gan Chen, Lian Zhao, Quan Wang, Hong Mei Zhou · 2023 · Artificial Cells Nanomedicine and Biotechnology
30. Extra-Cellular Vesicles Derived from Thyroid Cancer Cells Promote the Epithelial to Mesenchymal Transition (EMT) and the Transfer of Malignant Phenotypes through Immune Mediated Mechanisms
    S. Mardente, Michele Aventaggiato, E. Splendiani, E. Mari, A. Zicari, G. Catanzaro, A. Pò, Lucia Coppola, M. Tafani · 2023 · International Journal of Molecular Sciences
31. The role and therapeutic potential of glucose metabolism in multidrug resistance of cancer
    Qijing Wang, Kai Li, Liang Li, Li Qin, Yanyu Qi, Kai Liu, Hang Yuan, Ping Lin · 2025 · Frontiers in Cell and Developmental Biology
32. Poly l-Lactic Acid Nanofiber Membrane Effectively Inhibits Liver Cancer Cells Growth and Prevents Postoperative Residual Cancer Recurrence
    Yan-Xu Li, Wei-Ben Ji, Chao-Ying Wang, Lai Chang, Quan Zhang, Jie-Feng Gao, Tao Wang, Wei Wu · 2024 · ACS Applied Materials and Interfaces
33. Hypoxia Potentiated Lung Cancer Cell Migration and Invasion by up-regulating HIF1α/JAK2/STAT3 Axis and Activating MMP13 Transcription
    Xiaoju Cheng, Damin Liang, Xiaoqian Li, Chengmin Deng, Meng Ye, Yang Jiao, Yurui Liu, Kaifeng Wu, Jie Wu, Peng Tian · 2023 · Cell Biochemistry and Biophysics
34. Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH
    Xiaoyu Liu, Qingqing Tan, Jiaqi Wen, Xufei Wang, Gang Yang, Yuxiao Li, Ming Lu, Wei-Fa Ye, An-Feng Si, Sujuan Ma et al. · 2023 · Journal of Translational Medicine
35. Hypoxia-driven metabolic heterogeneity and immune evasive behaviour of gastrointestinal cancers: Elements of a recipe for disaster
    Ashish Kumar Mishra, Siddharth Singh, Sruthilaya Dayanandan, Smaran Banerjee, Soumyadeep Chakraborty, Akshita Baiju Gopal, Supriya Samal, Indrajit Poirah, Debashish Chakraborty, Asima Bhattacharyya · 2022 · Cytokine
36. HCG15 is a hypoxia-responsive lncRNA and facilitates hepatocellular carcinoma cell proliferation and invasion by enhancing ZNF641 transcription.
    Honglin Yan, Na He, Shui-Xiang He · 2022 · Biochemical and Biophysical Research Communications - BBRC
37. HBV reprograms the tumor microenvironment in hepatocellular carcinoma: mechanisms and therapeutic implications
    X Shen, Hechen Huang, Jianpeng Sheng, Xiaofeng Tang · 2026 · Clinical and Experimental Medicine
38. Responsive fluorescent probes for the imaging of cancer
    Shengyao Wang, Xiaojuan Yang, Zhe Zhang, Huanqing Zhang, Guanduo Wang, Zhenxing Liu, Yong Wen, Shengyun Huang · 2025 · Bioorganic Chemistry
39. Liver microenvironment and therapy resistance in hepatocellular carcinoma
    Kosar Rahi, Mehdi Hedayati, Zahra Hendi, Mustapha Najimi, Massoud Vosough · 2025 · Critical Reviews in Oncology/Hematology
40. Hypoxia Imaging in Lung Cancer: A PET-Based Narrative Review for Clinicians and Researchers
    Ahmad Alenezi, Hamad Alhamad, Aishah Alenezi, Muhammad Umar Hayat Khan · 2025 · Pharmaceuticals
41. Spermidine synthase promotes liver cancer progression in a paracrine manner by altering the macrophage immunometabolic state.
    Sihang Yu, Yuanxin Zhao, Qingqing Liu, Jian Wang, Jia-Ying Fu, Runyuan Li, Yuan Yuan, Xiaoyu Yan, Jing Su · 2025 · Bioorganic chemistry (Print)
42. Exploring the prognostic and therapeutic value of HIF1A in lung adenocarcinoma
    Zhimin Lu, Ya-Tong Bi, Jia-Lu Jiang, Xuming Yao, Guoxin Hou · 2024 · Heliyon
43. Unveiling the Impact of BMP9 in Liver Diseases: Insights into Pathogenesis and Therapeutic Potential
    Han Chen, Ying-Yi Li, Kouki Nio, Hong Tang · 2024 · Biomolecules
44. Cellular signaling in the hypoxic cancer microenvironment: Implications for drug resistance and therapeutic targeting.
    H. Bakshi, Michella Mkhael, Hakkim L. Faruck, A. U. Khan, Alaa A. A. Aljabali, V. Mishra, M. El-Tanani, N. Charbe, M. Tambuwala · 2023 · Cellular Signalling
45. Quantitative phosphoproteomics reveals molecular pathway network alterations in human early-stage primary hepatic carcinomas: potential for 3P medical approach
    Yu-Ping Zhang, Na Li, Lamei Yang, Wenshuang Jia, Zhijun Li, Qianwen Shao, Xian-Quan Zhan · 2023 · The EPMA Journal
46. An edoplasmic reticulum-targeted NIR fluorescent probe with a large Stokes shift for hypoxia imaging
    Ting Lan, Nan Ji, Qinqin Tian, Yu Zhan, Wei He · 2022 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
47. Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents
    Z. Xiong, Weiling Huang, W. Zhong, Jianchang Fu, Jikun Feng, Xi Wang, F. Ling · 2022 · Frontiers in Molecular Biosciences
48. Identification and Validation of a Hypoxia-Immune-Based Prognostic mRNA Signature for Oral Squamous Cell Carcinoma
    Shao-dong Lv, Zhi-Peng Qian, Jian-Hao Li, S. Piao, Ji-Chen Li · 2022 · Journal of Oncology
49. Novel hypoxia features with appealing implications in discriminating the prognosis, immune escape and drug responses of 947 hepatocellular carcinoma patients
    Ming-Yuan Luan, H. Si · 2021 · Translational Cancer Research
50. Metabolic reprogramming in the pathogenesis and progression of nasopharyngeal carcinoma: molecular mechanisms and therapeutic implications.
    Hong-Li Wang, Jian-Dao Hu, Wei-Bang Zhou, Ai-Juan Qian · 2024 · American Journal of Cancer Research
51. Construction of a radiogenomic signature based on endoplasmic reticulum stress for predicting prognosis and systemic combination therapy response in hepatocellular carcinoma
    Huai-Yu Wu, Shu-Ya Cao, Zheng Xu, Tian- Wang, G. Ji, Ke Wang · 2025 · BMC Cancer
52. Development of an AI model for predicting hypoxia status and prognosis in non-small cell lung cancer using multi-modal data
    Lina Zhou, Chenkai Mao, Ting-Ting Fu, X. Ding, Luca Bertolaccini, Ao Liu, Jun-Jun Zhang, Shi-Cheng Li · 2024 · Translational Lung Cancer Research
53. The crosstalk between cellular survival pressures and N6-methyladenosine modification in hepatocellular carcinoma.
    Chu-Li Fu, Zheng Zhao, Qiang Zhang · 2024 · Hepatobiliary & Pancreatic Diseases International
54. Dual‑regulated oncolytic adenovirus carrying ERCC1‑siRNA gene possesses potent antitumor effect on ovarian cancer cells
    Ting Zhao, Wei Ye, Rui Zhang, Xiaoyan Zhu, Qin Shi, Xiao-Feng Xu, Weifeng Chen, Ling Xu, Yaping Meng · 2024 · Molecular Medicine Reports
55. The regulation of hypoxia-related lncRNAs in hepatocellular carcinoma
    Xue-Jing Wang, Xiao-Jun Wang · 2024 · Discover Oncology
56. Physcion increases the sensitivity of hepatocellular carcinoma to sorafenib through miRNA-370/PIM1 axis-regulated glycolysis
    Xiaoping Pan, B. Jiya, Feng Wang, Zhu Lan · 2023 · World Journal of Gastrointestinal Oncology
57. Clinical Significance of Combined Epithelial–Mesenchymal Transition Markers Expression and Role of Rac1 in Hepatocellular Carcinoma
    Seung-Kak Shin, Sujin Ryu, Seungyoon Nam, Ye-On-Ha Seung, O. Kwon, Y. Kim, Se-Hee Kim, Ju ng-Hyun Kim · 2023 · International Journal of Molecular Sciences
58. WWOX-rs13338697 genotype predicts therapeutic efficacy of ADI-PEG 20 for patients with advanced hepatocellular carcinoma
    Yu-De Chu, Hui-fen Liu, Yi-Chen Chen, Chun-Hung Chou, Chau-Ting Yeh · 2022 · Frontiers in Oncology
59. Metabolic enzyme PFKFB3 mediates matrix stiffness‐potentiated tumour growth and radiotherapeutic resistance in HCC
    Mi-Mi Wang, Jia-Jun Li, Jia-Li Qian, Xi Zhang, Miao Li, Ying-Ying Zhao, Zhi-Ming Wang, Kun Guo, Dongmei Gao, Yan Zhao et al. · 2025 · Clinical and Translational Medicine
60. Advancements in research on the role of the key glycolytic enzyme hexokinase 2 in the regulation of tumor immune evasion (Review)
    Yiyang Qian, Xiao-Dan Zhu, Dong Niu, Quan Tang, Chun-Hui Jin · 2025 · Oncology Letters
61. Colon cancer cells evade drug action by enhancing drug metabolism
    Bojie Cong, Teena Thakur, Alejandro Huerta Uribe, Evangelia Stamou, Sindhura Gopinath, Owen James Sansom, Oliver D.K. Maddocks, Ross Leigh Cagan · 2025 · Oncogene
62. Prediction of Macrotrabecular-Massive Hepatocellular Carcinoma and Associated Prognosis Using Contrast-enhanced US and Clinical Features.
    Jia-Peng Wu, Si-Si Liu, Yi-Qiong Zhang, Wen-Zhen Ding, Qin-Xian Zhao, Yuling Wang, Fan Xiao, Xiao-Ling Yu, Xiao-Yan Xie, Shu-Hong Liu et al. · 2025 · Radiology: Imaging Cancer
63. The Effect of Ethanolic Extract of Brazilian Green Propolis and Artepillin C on Cytokine Secretion by Stage IV Glioma Cells Under Hypoxic and Normoxic Conditions
    Małgorzata Kłósek, Anna Kurek-Górecka, R. Balwierz, G. Pietsz, Z. Czuba · 2025 · Pharmaceuticals
64. Artificial Intelligence and Machine Learning Predicting Transarterial Chemoembolization Outcomes: A Systematic Review
    Elina Cho, Michelle Law, Zhen-Ning Yu, Jie N. Yong, C. Tan, E. Tan, Hirokazu Takahashi, P. Danpanichkul, Benjamin Nah, G. Soon et al. · 2024 · Digestive Diseases and Sciences
65. Pathological roles of lncRNA HOTAIR in liver cancer: An updated review.
    Chou-Yi Hsu, Azfar Jamal, Mohammad Azhar Kamal, Fuzail Ahmad, D. Bokov, Yasser Faki Mustafa, Abdulnaser Saud, S. Kulsum, M. Jawad, Baneen C. Gabble · 2024 · Gene
66. Multi-omics Insights into PDHA1 as a Predictive Biomarker for Prognosis, Immunotherapy Efficacy, and Drug Sensitivity in Hepatocellular Carcinoma
    Yong Pan, Yi-Ru Zhang, Dai-Wen Mao, Zhou Fang, Ying Ma, Dan-Wen Jin, Shi-Bo Li · 2024 · ACS Omega
67. Mitochondrial Protein Density, Biomass, and Bioenergetics as Predictors for the Efficacy of Glioma Treatments
    Gulnaz Sharapova, Sirina Sabirova, Marina O. Gomzikova, Anna I. Brichkina, Nick A. Barlev, Natalia V. Kalacheva, Albert Anatolyevich Rizvanov, Nikita Markov, Hans‐Uwe Simon · 2024 · International Journal of Molecular Sciences
68. Hypoxia‐inducible factor‐1α contributes to the proliferation of cholesteatoma keratinocytes through regulating endothelin converting enzyme 1 expression
    Nie Chen, Lei Xu, Zhi-Bin Bi, Jian Wu · 2024 · Laryngoscope Investigative Otolaryngology
69. Activation of CYP3A by Accelerated Blood Clearance Phenomenon Potentiates the Hepatocellular Carcinoma-Targeting Therapeutic Effects of PEGylated Anticancer Prodrug Liposomes
    Xue Zhang, Jianquan Pan, Xi Ye, Yun-Na Chen, Lei Wang, Xiang-Yun Meng, Wei-Dong Chen, Fengling Wang · 2023 · Drug Metabolism And Disposition
70. Bevacizumab-loaded CalliSpheres beads: in vitro loading, release profiles and application in rabbit liver VX2 tumor model
    Ke-Wei Ren, Ya-Hua Li, Zihe Zhou, Kun-Peng Wu, Jianan Wang, Jian-Ning Yao, Yi-Fan Li, X. Ge, Xiao Li, Zhen Li et al. · 2023 · Frontiers in Oncology
71. Evaluation of Hypoxia in Hepatocellular Carcinoma Using Quantitative MRI: Significances, Challenges, and Advances
    Mei-Cheng Chen, Xiao-Qi Zhou, Hua-Song Cai, Di Li, Chen-Yu Song, Hua-Yu You, Rui-Xia Ma, Zhi Dong, Zhen-Peng Peng, Shi-Ting Feng · 2023 · Journal of Magnetic Resonance Imaging
72. H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
    Sihang Yu, Lei Zhou, Jia-Ying Fu, Long Xu, Buhan Liu, Yuanxin Zhao, Jian Wang, Xiaoyu Yan, Jing Su · 2022 · Frontiers in Immunology
73. Network Pharmacology and Molecular Docking Approach to Reveal the Immunotherapeutic Mechanism of Cuscutae Semen in Treating Thin Endometrium
    Wenyan Zhang, Yuan Yuan, Guangrong Huang · 2022 · Journal of Immunological Research
74. Single-cell metabolic accumulation analysis by microfluidic hydrogel microspheres combined with mass spectrometry
    Gaowa Xing, Hongren Yao, Zengnan Wu, Yuxuan Li, Ying Hou, Jin‐Ming Lin · 2025 · Chemical Science
75. The roles of enhancer, especially super-enhancer-driven genes in tumor metabolism and immunity
    Shouwu Guo, Lu Zhang, Jiao Ren, Zhong Lü, Xiaolin Ma, Xinling Liu, Hongchuan Jin, Jiaqiu Li · 2025 · International Journal of Biological Macromolecules
76. 3D Bioprinted Multidrug Resistance (MDR)-Dependent Tumor Spheroids
    Minki Hong, Sera Hong, Joon Myong Song · 2025 · ACS Applied Materials & Interfaces
77. Hydrocortisone interacts with endoplasmic reticulum stress in hypoxic regulation of phosphoserine aminotransferase 1 gene expression differently in normal human astrocytes and glioblastoma cells
    О. H. Minchenko, Anastasiia I. Abramchuk, Yevgen P. Khikhlo, Myroslava Y. Sliusar, Oleh V. Halkin, Olha Y. Luzina, Serhiy V. Danilovsryi, Yuliia M. Viletska, Dmytro O. Minchenko · 2025 · Endocrine Regulations
78. The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering
    Baiheng Zhu, Kehao Xiang, Tanghua Li, Xin Li, Fujun Shi · 2024 · Cell Communication and Signaling
79. Emerging roles of long noncoding RNA H19 in human lung cancer
    Irfan Ahmad, S. Jasim, Klunko Nataliya Sergeevna, R. Jyothi S., Ashwani Kumar, Abdigafur Dusanov, Mahmood Hasen Shuhata Alubiady, Aashna Sinha, S. H. Zain Al-Abdeen, A. Hjazi · 2024 · Cell Biochemistry and Function
80. Unveiling the role of the KLF4/Lnc18q22.2/ULBP3 axis in the tumorigenesis and immune escape of hepatocellular carcinoma under hypoxic condition
    Lifang Wei, Ping He, Zhongqiu Tan, Li-Feng Zhao, Cheng Lin, Zhongheng Wei · 2024 · Journal of Cellular and Molecular Medicine
81. Combined BRAF and PIM1 inhibitory therapy for papillary thyroid carcinoma based on BRAFV600E regulation of PIM1: Synergistic effect and metabolic mechanisms
    Qian-Qian Xu, Jiaqi Wang, Yuting Mao, Ziyang Xuan, Yang Ke, Xi Tang, Xin Zhu · 2024 · Neoplasia
82. Impact of Hypoxia on Radiation-Based Therapies for Liver Cancer
    Alexander Villalobos, Jean Y. H. Lee, Sarah A. Westergaard, Nima Kokabi · 2024 · Cancers
83. Development and Validation of a Novel Nomogram Integrated with Hypoxic and Lactate Metabolic Characteristics for Prognosis Prediction in Hepatocellular Carcinoma
    Xun Qiu, Li-Bin Dong, Kai Wang, Xinyang Zhong, Han-Zhi Xu, Sheng-Jun Xu, Hai-Jun Guo, Xu-Yong Wei, Wei Chen, Xiao Xu · 2024 · Journal of Hepatocellular Carcinoma
84. Fatty acid metabolism-related genes as a novel module biomarker for kidney renal clear cell carcinoma: Bioinformatics modeling with experimental verification
    Zongming Jia, Zhenyu Fu, Ying Kong, Chengyu Wang, Bin Zhou, Yuxin Lin, Yuhua Huang · 2023 · Translational Oncology
85. Development and validation of a combined hypoxia and ferroptosis prognostic signature for breast cancer
    J. Zhong, Xi Shen, Jun-Jie Zhou, He-Ping Yu, Bi-Rong Wang, Jianbin Sun, Junchang Wang, Feng Liu · 2023 · Frontiers in Oncology
86. A prospective diagnostic and prognostic biomarker for hepatocellular carcinoma that functions in glucose metabolism regulation: Solute carrier family 37 member 3.
    Zi-Yu Meng, Xue Geng, Xiao-Yue Lin, Ziwei Wang, Dan-Ming Chen, Hua Liang, Ying Zhu, Yu-Tong Sui · 2023 · Biochimica et Biophysica Acta - Molecular Basis of Disease
87. Targeting hypoxia-related metabolism molecules: How to improve tumour immune and clinical treatment?
    Bing Liang, Linhong Deng, Xiuhua Zhou · 2022 · Biomedicine & Pharmacotherapy
88. Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis
    Bin Yu, Maoru Wang, Hui Xu, Rongrong Gao, Yuanying Zhu, Hong Ning, Xiao-Yu Dai · 2022 · BioMed Research International
89. Computational Repurposing and Experimental Validation of YBX1 Inhibitors in Hepatocellular Carcinoma
    Omar Karkoutly, V. Nagati, Subhash C. Chauhan, Manish K. Tripathi · 2026 · Biomedicines
90. Identification of potential molecular targets of luteolin in the treatment of hepatocellular carcinoma based on network pharmacology and transcriptome sequencing technology
    Yun-Qi Han, Hui-Jun Wu, Xin Zhang, Wei Lv, Yang Xiong, Xinyuan Tian, Yun-Feng Xiao, H. Cui · 2025 · Discover Oncology
91. LncRNA CRNDE and HOTAIR: Molecules behind the scenes in the progression of gastrointestinal cancers through regulating microRNAs
    Mohamed Jamal Saadh, Soumya Vettiyatil Menon, Rajni Verma, G.V. Siva Prasad, Omer Qutaiba B. Allela, Morug Salih Mahdi, Nabeel Ahmad, Beneen Husseen · 2024 · Pathology - Research and Practice
92. Anti-hepatoma effect of homologous delivery of doxorubicin by HepG2 cells
    Lina Sun, Baonan Ma, Fangzhou Yang, Hang Zou, Yifei Guo, Xiangtao Wang, Meihua Han · 2024 · International Journal of Pharmaceutics
93. Pyroptosis-related genes features on prediction of the prognosis in liver cancer: An integrated analysis of bulk and single-cell RNA sequencing
    Zhihao Zhang, Feng Liu, X. Lan, Fu-Hai Wang, Jia-Hao Sun, Hong-Long Wei · 2024 · Heliyon
94. Integrated Bioinformatic Analysis Reveals the Oncogenic, Survival, and Prognostic Characteristics of TPX2 in Hepatocellular Carcinoma
    Wei-Bin Zhang, Jia Dong, Yun-Fei Wu, Xiang-Nan Liang, Li-Da Suo, Liming Wang · 2024 · Biochemical Genetics
95. The ras-related protein RAB22A interacts with hypoxia-inducible factor 1-alpha (HIF-1α) in MDA-MB-231 breast cancer cells in hypoxia
    N. Papanikolaou, Maria Kakavoulia, Christos Ladias, Athanasios G. Papavassiliou · 2024 · Molecular Biology Reports
96. Deciphering the role of non-coding RNAs involved in sorafenib resistance
    Fan-Jing Jing, Yun-Yan Shi, Dong Jiang, Xiao Li, Jialin Sun, Xiaolei Zhang, Qie Guo · 2024 · Heliyon
97. Comprehensive Analysis of circRNA, lncRNA, miRNA and mRNA Expression Profiles and Their Competing Endogenous RNA Networks in Hepatitis B Virus-Related Hepatocellular Carcinoma
    Shaoying Yan, Peng Fu, Hui-Ming Li, Zikun Huang, Renfeng Shan, Binbin Gong · 2024 · Molecular Biotechnology
98. Hypoxia-induced circRTN4IP1 promotes progression and glycolysis of hepatocellular carcinoma cells
    Xijing Yang, Cheng Lou, Qing Hua Zhang, Guofang Liu, Yongmei Ding, Qian Zhang, Chun Ye · 2023 · Functional & Integrative Genomics
99. Hypoxia-induced PPFIA4 accelerates the progression of ovarian cancer through glucose metabolic reprogramming
    Shu Tan, Hao Yu, Ye Xu, Yue Zhao, G. Lou · 2023 · Medical Oncology
100. Necrotic and apoptotic adipocytes in the hypoxic tumor microenvironment supply triglycerides to induce cisplatin resistance in the metastatic lymph nodes of head and neck carcinoma
     Fei-ran Li, Hui-Ying Huang, Qian Huang, Xin-Hui Mao, N. Cong, Wen-Jie Zhuang, Chi-Yao Hsueh, Ming Zhang · 2025 · Cell Death and Disease